Prevention of invasive pneumococcal disease in HIV-infected children: Expanding the toolbox

Journal of Infectious Diseases

Volumn 199, Issue 8, 2009, Pages 1109-1111

  Abzug, Mark J ^a   Pelton, Stephen I ^b,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PLACEBO; PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; CHILD HEALTH CARE; CLINICAL TRIAL; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFECTION PREVENTION; INVASIVE PNEUMOCOCCAL DISEASE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; VACCINATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HUMANS; INFANT; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SOUTH AFRICA; UNITED STATES;

EID: 65649136893     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597389     Document Type: Editorial

References (15)

1. Mao C, Harper M, McIntosh K, et al.Invasive pneumococcal infections in human immunodeficiency virus-infected children. J Infect Dis 1996; 173:870-6.
2. Westwood AT, Eley BS, Gilbert RD, Hanslo D. Bacterial infection in children with HIV: a prospective study from Cape Town, South Africa. Ann Trop Paediatr 2000; 20:193-8.
3. Kapogiannis BG, Soe MM, Nesheim SR, et al.Trends in bacteremia in the pre- and posthighly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004). Pediatrics 2008; 121:e1229-39.
4. Gona P, Van Dyke RB, Williams PL, et al.Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA 2006; 296:292-300.
5. Steenhoff AP, Wood SM, Rutstein RM, Wahl A, McGowan KL, Shah SS. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006. Pediatr Infect Dis J 2008; 27:886-91.
6. Flannery B, Heffernan RT, Harrison LH, et al.Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Int Med 2006; 144:1-9.
7. Klugman KP, Madhi SA, Huebner RE, Kohlberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. Vaccine Trialists Group. N Engl J Med 2003; 349:1341-8.
8. Nachman S, Kim S, King J, et al.Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics 2003; 112:66-73.
9. Madhi SA, Kuwanda L, Cutland C, Holm A, Käyhty H, Klugman KP. Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2005; 24:410-6.
10. Madhi SA, Adrian P, Kuwanda L, et al.Long-term immunogenicity and efficancy of a 9-valent conjugate pneumococcal vaccine in human immunodeficiency virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine 2007; 25:2451-7.
11. Madhi SA, Klugman KP, Kuwanda L, Cutland C, Käyhty H, Adrian P. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIVinfected and HIV-uninfected children 5 years after vaccination. J Infect Dis 2009; 199: 1168-76 (in this issue).
12. Abzug MJ, Pelton SI, Song L, et al.Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J 2006; 25:920-9.
13. Brena AE, Cooper ER, Cabral HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr 1993; 6:1125-9.
14. Moss WJ, Scott S, Mugala N, et al.Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis 2007; 196:347-55.
15. Abzug MJ, Song L, Fenton, et al.Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Pediatrics 2007; 120:e1190-202.